Very high risk prostate case

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

CodeRedDew

Thirst Quencher
10+ Year Member
Joined
Nov 13, 2011
Messages
500
Reaction score
132
Hello all,

Just wanted to get thoughts regarding a unique case.

55 y/o male with non-secretory GS 5+4 prostate cancer following RP/LND 2-3 years ago and treated with adjuvant long-term ADT alone, who now presents with a local bladder recurrence s/p salvage cystectomy with multiple +margins. No gross disease on post-op MRI and Axumin just shows mild avidity in the operative bed but no mets.

What is the role for XRT in his case? Specifically, what would be your treatment volumes and to what dose would you treat?

Initial management at diagnosis was at an outside PP center and it’s unclear why he wasn’t at least referred to discuss adjuvant XRT following initial surgery. Although his post-op PSAs have remained undetectable given non-secretory histology (iPSA was ~2).


Sent from my iPhone using SDN mobile
 
Questions:

1. What's in the place of the bladder? Neobladder? Ordinary bowel?

2. Did the recurrence arise during/shortly after long-term ADT? Would you classify this tumor as HSPC or CRPC?
 
Questions:

1. What's in the place of the bladder? Neobladder? Ordinary bowel?

2. Did the recurrence arise during/shortly after long-term ADT? Would you classify this tumor as HSPC or CRPC?

1) Ordinary bowel (ileal conduit)

2) About ~10 months or so following cessation of ADT (presented with AKI). And I would say HSPC - MedOnc restarted ADT a couple months prior to cystectomy.


Sent from my iPhone using SDN mobile
 
I would. Try to guesstimate where postitive margin would be, and boost bed inferior to top of femoral heads to as high as possible. Would think that preop scan could possibly help for boost.

I know there is some data on radiosensitizing doses of taxanes for intact prostate as had pt on such a trial many years ago. May not be a bad idea to consider.
 
The problem is going to be the ileal conduit.

You would prefer to put something like 66 (+) Gy in those positive margin areas but the ileal conduit (and its constraints) are going to ruin your dose distribution. I am not sure if widely accepted constraints for ileal conduit exist, but I wouldn't like to go above 54 Gy point dose.
 
Ileal conduit is as radiosensitive as any small bowel, so I'd keep the total dose < 60 Gy.
A unique case, never seen anything like that.
 
Last edited:
The ileal conduit should be a significant distance away from the prostatic fossa. If your positive margins were in the region of the bladder neck and trigone it will likely just be ordinary bowel filling that space that you need to worry about.

Interesting case. Did he progress while on his adjuvant ADT or afterwards? If during then I’d call him non metastatic crpc and give ADT plus docetaxel or Apilutamide, favoring the former if good PS.
 
The ileal conduit should be a significant distance away from the prostatic fossa. If your positive margins were in the region of the bladder neck and trigone it will likely just be ordinary bowel filling that space that you need to worry about.

Interesting case. Did he progress while on his adjuvant ADT or afterwards? If during then I’d call him non metastatic crpc and give ADT plus docetaxel or Apilutamide, favoring the former if good PS.


He progressed ~10 months following ADT, which was restarted a couple of months prior to cystectomy.


Sent from my iPhone using SDN mobile
 
Top